Second Opinion doesn't hold back. Join Christina Farr, Ash Zenooz, Luba Greenwood, as they bring influential entrepreneurs, experts and investors into the ring for candid conversations at the frontlines of healthcare and digital health every week. Episode 1 with Robin Berzin, CEO of Parsley Health, will be available starting on July 31, 2024. Subscribe to Second Opinion wherever you get your podcasts. Learn more at https://www.podpage.com/secondopinion/

Til then, meet your hosts:

Christina Farr draws on a decade of experience covering the industry as a reporter at CNBC, Fast Company and Reuters, as well as an investor at OMERS Ventures. During her tenure as a reporter, she broke some big health-tech stories ranging from Amazon’s first moves into the sector to Apple’s secretive acquisitions.

Luba Greenwood, JD is a veteran biotech CEO and investor. She is the managing partner and founder of the Dana-Farber Cancer Institute venture fund and has served as CEO and Chair of multiple companies including Kojin. She has led over $10b in deals and served in leadership roles at large healthcare and tech companies, including Roche and Google. She is a thought leader in the industry and senior lecturer at Harvard.

Ash Zenooz, MD — former CEO of Commure and partner at Luxeda Holdings. As former CEO of Commure, she drove over 550% ARR growth and led a merger. Previously, she grew Salesforce's global health and life sciences unit to $2.5b ARR. Ash also served as Chief Medical Officer at the VA, overseeing an $80B portfolio and leading telehealth and precision medicine reforms.

This season, we’re tackling meaty topics like biosecurity, the latest in telemedicine, why patient acquisition is so hard, and the pros and cons of VC versus private equity in funding startups in the healthtech space.

Introducing Second Opinion